<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">tiblj</journal-id><journal-title-group><journal-title xml:lang="ru">Туберкулез и болезни легких</journal-title><trans-title-group xml:lang="en"><trans-title>Tuberculosis and Lung Diseases</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2075-1230</issn><issn pub-type="epub">2542-1506</issn><publisher><publisher-name>Медицинские знания и технологии</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21292/2075-1230-2021-99-4-30-35</article-id><article-id custom-type="elpub" pub-id-type="custom">tiblj-1528</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Исследование элюционных характеристик противотуберкулезных препаратов, смешанных с костным цементом</article-title><trans-title-group xml:lang="en"><trans-title>Study of elution characteristics of anti-tuberculosis drugs mixed with bone cement</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Перецманас</surname><given-names>Е. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Peretsmanas</surname><given-names>E. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Перецманас Евгений Оркович – руководитель отдела исследований внелегочного туберкулеза</p><p>127473, Москва, ул. Достоевского, д. 4, кор. 2</p></bio><bio xml:lang="en"><p>Evgeniy O. Peretsmanas – Head of Extrapulmonary Tuberculosis Research Department</p><p>Build. 2, 4, Dostoevskiy St., Moscow, 127473</p></bio><email xlink:type="simple">peretsmanas58@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Артюхов</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Аrtyukhov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Артюхов Александр Анатольевич – профессор кафедры биоматериалов</p><p>125047, Москва, Миусская пл., д. 9</p></bio><bio xml:lang="en"><p>Aleksandr A. Artyukhov – Professor of Biomaterials Department</p><p>9, Miusskaya St., Moscow, 125047</p></bio><email xlink:type="simple">artyukhow@muctr.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Штильман</surname><given-names>М. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Shtilman</surname><given-names>M. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Штильман Михаил Исаакович – профессор кафедры биоматериалов</p><p>125047, Москва, Миусская пл., д. 9</p></bio><bio xml:lang="en"><p>Mikhail I. Shtilman – Professor of Biomaterials Department</p><p>9, Miusskaya St., Moscow, 125047</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Есин</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Esin</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Есин Игорь Викторович – старший научный сотрудник отдела исследований внелегочного туберкулеза</p><p>127473, Москва, ул. Достоевского, д. 4, кор. 2</p></bio><bio xml:lang="en"><p>Igor V. Esin – Senior Researcher of Extrapulmonary Tuberculosis Research Department</p><p>Build. 2, 4, Dostoevskiy St., Moscow, 127473</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зубиков</surname><given-names>В. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Zubikov</surname><given-names>V. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p> </p><p>Зубиков Владимир Сергеевич – ведущий научный сотрудник отдела исследований внелегочного туберкулеза</p><p>127473, Москва, ул. Достоевского, д. 4, кор. 2</p></bio><bio xml:lang="en"><p>Vladimir S. Zubikov – Leading Researcher of Extrapulmonary TuberculosisResearch Department</p><p>Build. 2, 4, Dostoevskiy St., Moscow, 127473 </p></bio><email xlink:type="simple">zubikovladimir@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Герасимов</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gerasimov</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Герасимов Илья Александрович – врач – травматолог-ортопед туберкулезного отделения для больных внелегочным туберкулезом</p><p>127473, Москва, ул. Достоевского, д. 4, кор. 2</p></bio><bio xml:lang="en"><p>Ilya A. Gerasimov – Traumatologist and Orthopedist of Extrapulmonary Tuberculosis Unit Department</p><p>Build. 2, 4, Dostoevskiy St., Moscow, 127473</p></bio><email xlink:type="simple">ilya-1559@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний» МЗ РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center of Phthisiopulmonology and Infectious Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Российский химико-технологический университет им. Д. И. Менделеева» Минобрнауки РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Mendeleev University of Chemical Technology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>14</day><month>05</month><year>2021</year></pub-date><volume>99</volume><issue>4</issue><fpage>30</fpage><lpage>35</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Перецманас Е.О., Артюхов А.А., Штильман М.И., Есин И.В., Зубиков В.С., Герасимов И.А., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Перецманас Е.О., Артюхов А.А., Штильман М.И., Есин И.В., Зубиков В.С., Герасимов И.А.</copyright-holder><copyright-holder xml:lang="en">Peretsmanas E.O., Аrtyukhov A.A., Shtilman M.I., Esin I.V., Zubikov V.S., Gerasimov I.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.tibl-journal.com/jour/article/view/1528">https://www.tibl-journal.com/jour/article/view/1528</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования: оценка элюционных характеристик противотуберкулезных препаратов (изониазид, циклосерин, рифампицин, амикацин, канамицин, этамбутол), загруженных в образцы костного цемента и помещенных в жидкую среду для определения возможности использования подобных систем в качестве депо препарата.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Для исследования in vitro использовались химически чистые субстанции препаратов. Для изучения кинетики элюции препаратов применялся спектрофотометрический метод. Проведен анализ спектров поглощения препаратов в видимой и ультрафиолетовой области для выявления максимумов поглощения, и оценена устойчивость химической структуры препаратов к нагреванию. Далее изучена динамика выделения препаратов из образцов отвержденного костного цемента в статических условиях.</p></sec><sec><title>Результаты</title><p>Результаты. Получены удовлетворительные показатели термостабильности и элюции изучаемых препаратов, что позволяет использовать их в смеси с костным цементом.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>The objective</title><p>The objective: to assess the elution characteristics of anti-tuberculosis drugs (isoniazid, cycloserine, rifampicin, amikacin, kanamycin, ethambutol) placed into bone cement samples and put in a liquid medium to determine the possibility of using such systems as a drug reservoir.</p></sec><sec><title>Subjects and methods</title><p>Subjects and methods. For in vitro studies, pure substances of the drugs were used. The spectrophotometry was used to study the elution kinetics of the drugs. Absorption spectra of the drugs in the visible and ultraviolet regions were analyzed to reveal the absorption maxima, and the resistance of the chemical structure of the drugs to heating was assessed. Further, the changes of drug release from hardened bone cement samples under static conditions were studied.</p></sec><sec><title>Results</title><p>Results. It has been found that studied drugs demonstrated satisfactory parameters of thermal stability and elution which makes it possible to use them in a mixture with bone cement.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>элюция</kwd><kwd>спектры поглощения</kwd><kwd>устойчивость к нагреванию</kwd><kwd>противотуберкулезные препараты</kwd><kwd>костный цемент</kwd></kwd-group><kwd-group xml:lang="en"><kwd>elution</kwd><kwd>absorption spectra</kwd><kwd>resistance to heat</kwd><kwd>anti-tuberculosis drugs</kwd><kwd>bone cement</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Anagnostakos K., Meyer C. Antibiotic elution from hip and knee acrylic bone cement spacers: a systematic review // BioMed research international. – 2017. – Vol. 2017.</mixed-citation><mixed-citation xml:lang="en">Anagnostakos K., Meyer C. Antibiotic elution from hip and knee acrylic bone cement spacers: a systematic review. BioMed Research International, 2017, vol. 2017.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Athans V., Veve M. P., Davis S. L. Trowels and tribulations: review of antimicrobial‐impregnated bone cements in prosthetic joint surgery // Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. – 2017. – Vol. 37, № 12. – Р. 1565-1577.</mixed-citation><mixed-citation xml:lang="en">Athans V., Veve M.P., Davis S.L. Trowels and tribulations: review of antimicrobial‐impregnated bone cements in prosthetic joint surgery. Pharmacotherapy, The Journal of Human Pharmacology and Drug Therapy, 2017, vol. 37, no. 12, pp. 1565-1577.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Chang C. H., Hu C. C., Chang Y., Hsieh P. H., Shih H. N., Ueng S. W. N. Two-stage revision arthroplasty for Mycobacterium tuberculosis periprosthetic joint infection: An outcome analysis // PloS one. – 2018. – Vol. 13, № 9. – Р. e0203585.</mixed-citation><mixed-citation xml:lang="en">Chang C.H., Hu C.C., Chang Y., Hsieh P.H., Shih H.N., Ueng S.W.N.Two-stage revision arthroplasty for Mycobacterium tuberculosis periprosthetic joint infection: An outcome analysis. PloS one, 2018, vol. 13, no. 9, pp. e0203585.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Galvez-Lopez R., Pena-Monje A., Antelo-Lorenzo R., Guardia-Olmedo J., Moliz J., Hernandez-Quero J., Parra-Ruiz J. Elution kinetics, antimicrobial activity, and mechanical properties of 11 different antibiotic loaded acrylic bone cement // Diagn. Microbiol. Infect. Dis. – 2014. – Vol. 78, № 1. – Р. 70-74.</mixed-citation><mixed-citation xml:lang="en">Galvez-Lopez R., Pena-Monje A., Antelo-Lorenzo R., Guardia-Olmedo J., Moliz J., Hernandez-Quero J., Parra-Ruiz J. Elution kinetics, antimicrobial activity, and mechanical properties of 11 different antibiotic loaded acrylic bone cement. Diagn. Microbiol. Infect. Dis., 2014, vol. 78, no. 1, pp. 70-74.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Han C. D., Oh T., Cho S. N., Yang J. H., Park, K. K. Isoniazid could be used for antibiotic-loaded bone cement for musculoskeletal tuberculosis: an in vitro study // Clinical Orthopaedics and Related Research®. – 2013. – Vol. 471, № 7. – Р. 2400-2406.</mixed-citation><mixed-citation xml:lang="en">Han C.D., Oh T., Cho S.N., Yang J.H., Park, K.K. Isoniazid could be used for antibiotic-loaded bone cement for musculoskeletal tuberculosis: an in vitro study. Clinical Orthopedics and Related Research, 2013, vol. 471, no. 7, pp. 2400-2406.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lee J. H., Han C. D., Cho S. N., Yang I. H., Lee W. S., Baek S. H. How long does antimycobacterial antibiotic-loaded bone cement have in vitro activity for musculoskeletal tuberculosis? // Clinical Orthopaedics and Related Research®. – 2017. – Vol. 475, № 11. – Р. 2795-2804.</mixed-citation><mixed-citation xml:lang="en">Lee J.H., Han C.D., Cho S.N., Yang I.H., Lee W.S., Baek S.H. How long does antimycobacterial antibiotic-loaded bone cement have in vitro activity for musculoskeletal tuberculosis? Clinical Orthopedics and Related Research, 2017, vol. 475, no. 11, pp. 2795-2804.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Lee J. H., Shin S. J., Cho S. N., Baek S. H., Park K. K. Does the effectiveness and mechanical strength of kanamycin-loaded bone cement in musculoskeletal tuberculosis compare to vancomycin-loaded bone cement // J. Arthroplasty. – 2020. – Vol. 35, № 3. – Р. 864-869.</mixed-citation><mixed-citation xml:lang="en">Lee J.H., Shin S.J., Cho S.N., Baek S.H., Park K.K. Does the effectiveness and mechanical strength of kanamycin-loaded bone cement in musculoskeletal tuberculosis compare to vancomycin-loaded bone cement. J. Arthroplasty, 2020, vol. 35, no. 3, pp. 864-869.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Masri B. A., Duncan C. P., Jewesson P., Ngui-Yen J., Smith J. Streptomycin-loaded bone cement in the treatment of tuberculous osteomyelitis: an adjunct to conventional therapy // Canad. J. Surgery. – 1995. – Vol. 38, № 1. – Р. 64.</mixed-citation><mixed-citation xml:lang="en">Masri B.A., Duncan C.P., Jewesson P., Ngui-Yen J., Smith J. Streptomycin-loaded bone cement in the treatm ent of tuberculous osteomyelitis: an adjunct to conventional therapy. Canad. J. Surgery, 1995, vol. 38, no. 1, pp. 64.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
